EULAR 2021 – Day 4 Report
Lots of presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4.
RheumNow Podcast - Best of EULAR 2021
Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.
Israel provides COVID vaccine answers for rheumatic disease patients
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br
COLCORONA: Protective Effect of Colchicine in COVID-19
Lancet Respiratory Medicine has reported the results of the COLCORONA trial, showing that in patients with PCR-confirmed COVID-19 infection, colchicine led to a significantly lower rate of death or hospital admission from COVID.
RheumNow Podcast – Heart, Lung & Liver (5.28.2021)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Methotrexate Impairs COVID Vax Response
MedPage Today
One-third of patients with immune-mediated inflammatory diseases being treated with methotrexate showed attenuated responses to the COVID-19 vaccine, researchers reported.
Tocilizumab Augmented Efficacy in COVID-19 Pneumonia with High CRP
JAMA Internal Medicine report an analysis of recent and composite trial data suggesting that tocilizumab (TCZ) therapy in COVID-19–associated pneumonia patients with high CRP levels is likely to be effective.
Factors Associated with COVID-19 Deaths in Rheumatic Patients
Analysis of data from the COVID-19 Global Rheumatology Alliance shows that rheumatic diseases infected with COVID-19 had a greater risk of death with age, comorbidities, high disease activity and few specific therapies.
RheumNow Podcast – Myth Busters (5.21.2021)
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com
RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.
We love Rheumatology!
RheumNow Live 2021 Now Available for All
RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).
Social
During 2021-22, there was 387,112 deaths due to pneumonia, influenza, or COVID-19. At least 72% were dut to COVID-19 and 0.6% was due to influenza https://t.co/0ljpXJt0yr https://t.co/1Sp4RULVAY
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
🆕🌟CDC Guidance on COVID-19 Vaccines for Children <18 yrs who are Immunocompromised 👦👧🏾💉⬇️
Thank you Dr. Rebecca Sadun for reviewing!
#PedsTwitter #PedsRheum #Pediatrics https://t.co/eeuRKflhSO
Mithu Maheswaranathan, MD @MithuRheum ( View Tweet )
2 years 9 months ago
CDC: Immunocompromised account for 12.2% of all COVID-19 hospitalizations, with an increased risk of ICU (aOR=1.26) and death (aOR = 1.34), even if vaccinated (aOR 1.40; aOR = 1.87). In immunocompromised, death rate was not affected by vaccination. https://t.co/PVRnOPb9gX https://t.co/W2S9eb1cOo
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
New podcast up—“What Worries You, Masters You”
We review recent news, regulatory and guideline updates from the past week. Studies on MTX use, COVID vaccination, Supplements and vitamins, and arthrocentesis despite anticoagulation are discussed.
https://t.co/jRaLCQAt9K https://t.co/opa22JqU41
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
Patients in the COVID-19 Global Rheumatology Alliance were Surveyed; responses from 9300 Rheum Dz adults (RA 39%, SLE 31%) showed that 27% had a change in employment status during COVID (w/ 13.6% decrease in full-time employment) https://t.co/exi6KDmMGT https://t.co/fPl091rXdO
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
Two Week MTX Hold with COVID-19 Vaccination
A cohort study of RA patients evaluated immunogenicity of COVID vaccination with and without holding MTX for and 2-weeks and showed better immunogenicity, but more RA flares with the second MTX withdrawal.
https://t.co/Kqa8Uy9tDm https://t.co/UvMHo8xAw8
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
COVID-19 Death is Dependent on Age and Type I IFN Autoantibodies
https://t.co/WrWujgHoA4 https://t.co/NTwUeXHYKr
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
COVID-19 hospitalization among Medicare diabled was ~50% higher (3,148/100k) than age matched pop. , and hospitalization rates increased with age in both groups. Among the disabled, American Indian or Alaska Natives had highest rate https://t.co/Xa4NlalHdf https://t.co/dP0c3ajQAW
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
Review on reactive arthritis & COVID: 22 articles , 25 pts (14M:11F), age 45 yrs. Oligoarthritis was most common. Onset (COVID to arthritis) was 6-48 days. Steroids in 13, 2 w/ SSZ, Sxs improved 22/25, mean resolution was 16 +/- 57 days https://t.co/0YABcjz9Gk https://t.co/W5Vnn1NjkD
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 11 months ago
Spondyloarthritis and COVID-19
With the availability of vaccines and new therapeutics, many of our patients are fully vaccinated. We know this can limit their chances of severe COVID all while allowing their rheumatic disease to be treated. #EULAR2022
https://t.co/PmQNKYg1Ao https://t.co/N4DJVYJqrL
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 11 months ago
